What AI says about PaVe-GT

PaVe-GT is an NIH initiative that uses a platform vector approach with AAV to accelerate gene therapy development for rare genetic diseases.

AI mentioned PaVe-GT from October 2025 to July 2026.

Questions and answers

PaVe-GT in AI answers

What are the latest affordable advancements in biopharma for treating rare diseases?

ChatGPTChatGPTNo answer mentioning PaVe-GT
Google AI ModeGoogle AI Mode· Jul 20, 2026
Initiatives like PaVe-GT (NIH) aim to streamline gene therapy development by using a standardized adeno-associated virus (AAV) vector for multiple rare diseases

Sites AI cites

None of these answers cited pave-gt.ncats.nih.gov. AI cited pmc.ncbi.nlm.nih.gov, americangene.com, and biopharminternational.com.

Brands AI mentions

CASGEVY appeared in every answer that mentioned PaVe-GT.

For agents: this page as data
This page as data:    GET  https://parse.gl/api/public/brands/pave-gt-ncats-nih-gov
Ask about this brand: POST https://agent.parse.gl/v1/tools/check_brand   {"subject": "pave-gt.ncats.nih.gov"}
Search brands:        GET  https://parse.gl/api/public/search?q=<words>

No account: what this page shows, 5 example rows a list, about 120 brands a day per address.
Free account: $5 of credit, your own brand in full, a weekly check.
With credit: every row, history, and live checks at $0.01 each. Top up from $5.
Full text of a public answer: 25 a day free, then $0.005 each.
An agent can start a workspace with no account: POST https://agent.parse.gl/v1/workspaces

Connect an assistant: https://agent.parse.gl/mcp
Prices: https://parse.gl/pricing.md    Map of the site: https://parse.gl/llms.txt